Matches in Wikidata for { <http://www.wikidata.org/entity/Q71607775> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q71607775 description "article scientifique publié en 1996" @default.
- Q71607775 description "artikull shkencor i botuar më 01 shkurt 1996" @default.
- Q71607775 description "artículu científicu espublizáu en febreru de 1996" @default.
- Q71607775 description "im Februar 1996 veröffentlichter wissenschaftlicher Artikel" @default.
- Q71607775 description "scientific article published on 01 February 1996" @default.
- Q71607775 description "wetenschappelijk artikel" @default.
- Q71607775 description "наукова стаття, опублікована в лютому 1996" @default.
- Q71607775 name "Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial" @default.
- Q71607775 name "Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial" @default.
- Q71607775 name "Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial" @default.
- Q71607775 type Item @default.
- Q71607775 label "Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial" @default.
- Q71607775 label "Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial" @default.
- Q71607775 label "Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial" @default.
- Q71607775 prefLabel "Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial" @default.
- Q71607775 prefLabel "Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial" @default.
- Q71607775 prefLabel "Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial" @default.
- Q71607775 P1433 Q71607775-6DB64029-2749-4F56-AAFE-F10A1A91A904 @default.
- Q71607775 P1476 Q71607775-E3CB407E-3D31-4D27-A3A7-CD281B8D3525 @default.
- Q71607775 P2093 Q71607775-12A16181-9D19-4B37-8687-D33D00D0FA43 @default.
- Q71607775 P2093 Q71607775-27EEB2E4-244A-4809-91F2-00B53433CE8B @default.
- Q71607775 P2093 Q71607775-405486E0-9FB9-4D5A-A7AC-90E8F9DCAEF8 @default.
- Q71607775 P2093 Q71607775-53B16C3B-D14B-42A5-ACC6-E62EB63B98CA @default.
- Q71607775 P304 Q71607775-8A02BCA8-55DF-4538-BCB6-89136ACE7420 @default.
- Q71607775 P31 Q71607775-518680D9-0976-4326-BCCC-6665E3B2F5B1 @default.
- Q71607775 P356 Q71607775-230780DD-5D9C-4155-AA1E-21AF5051D612 @default.
- Q71607775 P433 Q71607775-A0C5A67F-10C1-4B68-A4C4-D2E6E974CB11 @default.
- Q71607775 P478 Q71607775-DBEB7C85-1B8A-4782-85A9-074CDBDE399D @default.
- Q71607775 P50 Q71607775-00D59B36-B820-487A-B331-1D1600D94F99 @default.
- Q71607775 P577 Q71607775-EF577079-497A-47D1-9DBD-D2BB1EF49BE1 @default.
- Q71607775 P698 Q71607775-96E35CD4-DA57-48B4-9F15-92A4CD80651B @default.
- Q71607775 P921 Q71607775-66D2937D-312A-414C-9D25-F31BC60B3830 @default.
- Q71607775 P356 0006-3223(95)00585-4 @default.
- Q71607775 P698 8837983 @default.
- Q71607775 P1433 Q4914961 @default.
- Q71607775 P1476 "Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial" @default.
- Q71607775 P2093 "Cooper TB" @default.
- Q71607775 P2093 "Javitt DC" @default.
- Q71607775 P2093 "Leiderman E" @default.
- Q71607775 P2093 "Zylberman I" @default.
- Q71607775 P304 "213-215" @default.
- Q71607775 P31 Q13442814 @default.
- Q71607775 P356 "10.1016/0006-3223(95)00585-4" @default.
- Q71607775 P433 "3" @default.
- Q71607775 P478 "39" @default.
- Q71607775 P50 Q57159010 @default.
- Q71607775 P577 "1996-02-01T00:00:00Z" @default.
- Q71607775 P698 "8837983" @default.
- Q71607775 P921 Q41112 @default.